1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma :A Multicenter, Real-World Clinical StudyALK-positive Advanced NSCLC; ALK-positive Non-small Cell Lung Cancer (NSCLC); MPR; Neoadjuvant TherapyNot yet recruitingPhase 42025-01-21NCT06785584